Dupuytren's disease (DD) is a benign progressive disease of the palmar aponeurosis that leads to a permanent and irreversible flexion contracture of the fingers. Various genetic aberrations ([@REF0007]) and environmental factors ([@REF0003]) have been linked to the development of DD. Local tissue damage can cause myofibroblast proliferation or tissue repair ([@REF0024], [@REF0021]).

Because of the similarities, parallels have been drawn between DD and wound healing ([@REF0022], [@REF0010], [@REF0021], [@REF0009]). Myofibroblasts are present in both DD and in wound healing, and play an important role throughout the wound healing process, eventually causing a large deposit of collagen III ([@REF0021]).

Wound healing is a complex, carefully regulated process requiring communication between different cell types. In normal tissues, fibroblasts are widely separated by extracellular matrix, but contact each other through elongated protoplasmic extensions. Communication is provided by gap junction (GJ) channels ([@REF0013], [@REF0016], [@REF0004]). These GJs allow the passage of small molecules, including ions and second messengers, between cells ([@REF0013]). The protein subunits of GJ channels are called connexins. Their composition is important for their selectivity regarding passage of molecules and---as a result---communication between cells ([@REF0013]). GJs have been shown to be important in cell proliferation, migration, and differentiation ([@REF0013], [@REF0016]). In recent years, it has been shown that connexins play a critical role in wound healing, and Cx26, Cx30, and Cx43 are involved in this process ([@REF0002]).

Connexin expression changes in the different stages of wound healing, and this is important in regulation of the process. Cx26, Cx30, and Cx43 expression is rapidly downregulated at the wound edge within 6 h of wounding. In the subsequent stages, cells at the edges continue to be Cx26- and Cx30-negative whereas cells behind the edges show upregulation. The loss of Cx43 staining in all cells of the regenerating epidermis appears to be important for induction of human wound healing ([@REF0005], [@REF0002], [@REF0006]). Additionally, connexins have recently been shown to directly control gene expression and cell migration ([@REF0012]).

3 connexins have been reported to have a role in human wound healing: Cx26, Cx30, and Cx43 ([@REF0002]). We determined the expression of Cx26, Cx30, and Cx43 in Dupuytren's tissue immunohistochemically, to investigate a possible involvement of GJ proteins in the pathogenesis of DD.

Patients and methods {#ss1}
====================

31 Caucasian patients with DD (mean age 56 (30--76) years, 24 male) who were consecutively treated surgically between April and December 2008 were included in this study ([Table 1](#T1){ref-type="table"}). Clinically, DD was diagnosed according to Iselin's 4-degree classification, as follows: first degree, palmar tubercles and small cords without signs of contracture; second degree, bending contracture within the metacarpophalangeal articulation; third degree, bending contracture affecting the proximal interphalangeal articulation; and fourth degree, severe contracture within the metacarpophalangeal articulation with hyperextension in the distal interphalangeal articulation, together with advanced secondary lesions in the osseous system ([@REF0011]).

###### 

Demographic data on patients with Dupytren's disease and carpal tunnel syndrome

                          Dupytren's   Controls [^a^](#T1-F1){ref-type="fn"}   
  ----------------------- ------------ --------------------------------------- ----------
  Number                  14           17                                      9
  Sex, F / M              2 / 12       4 / 13                                  6 / 3
  Mean age (SD)           54 (11)      61 (12)                                 62 (109)
  (range), years          (33--71)     (39--81)                                (44--79)
  Iselin classification                                                        
   Stage I                3/14         3/17                                    
   Stage II               3/14         5/17                                    
   Stage III              6/14         7/17                                    
   Stage IV               3/14         2/17                                    

**^a^**Carpal tunnel syndrome

Patients had either partial or total fasciectomy, and tissue samples of pathological palmar aponeurosis (Dupuytren's tissue) were taken during surgery, quick-frozen in Tissue-Tek Cryomold Standard (Miles Laboratories Inc., Kamkakee, IL) and stored frozen at --70°C. As a control, tissue was taken from the transverse carpal ligament of 9 patients (mean age 62 (44--79) years, 6 female) who were treated surgically for carpal tunnel syndrome.

The samples of Dupuytren's tissue were classified histologically according to the 3 distinct phases proposed by [@REF0015]. These describe the 3 phases of disease progression: (1) proliferative, (2) involutional, and (3) residual. The proliferative phase is almost entirely composed of myofibroblasts in highly cellular nodules. In the involution phase, which is still highly cellular, cells begin to align themselves along the lines of stress within the tissue. In the residual phase, which is almost acellular, myofibroblasts disappear leaving mature fibroblasts combined with thick bundles of collagen.

Immunohistochemistry {#ss2}
--------------------

To establish the myoﬁbroblast phenotype and the relationship between the GJ proteins Cx26, Cx30, and Cx43, we prepared representative serial sections of tissue samples from patients with DD and from controls.

Frozen tissue specimens were cut into 5-µm thick sections and produced on lysine-coated slides. Before immunostaining, the slides were dryed for 30 min at room temperature and then fixed in acetone for 10 min. Endogenous peroxidase activity was eliminated by incubation in 0.3% hydrogen peroxide for 3 min. For alfa-smooth muscle actin (α-SMA) determination, we used monoclonal mouse anti α-SMA (cat. no. A 2547; Sigma-Aldrich, St. Louis, MO). For different connexins, tissue sections were incubated overnight with the following primary antibodies: mouse monoclonal anti-Cx26 diluted 1:100 (cat. no. 13-8100), rabbit polyclonal anti-Cx30 diluted 1:500 (cat. no. 71-2200), and rabbit polyclonal anti-Cx43 diluted 1:500 (cat. no. 70-0700; all primary antibodies were from Invitrogen, Life Technologies, Carlsbad, CA). As secondary antibodies, we used biotin-labeled rabbit anti-mouse antibodies to detect the monoclonal primary antibodies and biotinylated goat anti-rabbit antibodies to detect polyclonal primary antibodies. This was followed by incubation with streptavidin. The reaction products were developed with 0.5% Triton X-100 (SERVA) and 10 µL hydrogen peroxide per 100 mL staining fluid, and 0.06% diaminobenzidine (Fluka, Buchs, Switzerland). Slides were counterstained with hematoxylin. The same immunohistochemical protocol was followed for negative controls, with omission of the primary antibodies. Blood vessels at the periphery of the tissue samples were used as an internal positive control.

Staining intensity of immunohistochemically stained sections was evaluated semi-quantitatively. A zero score defined slides with no staining, while 1+ referred to slides with a faint staining. A weak positive result characterized by weak staining corresponded to a 2+ score, while a strong positive result was represented by 3+. Scores of 0 were classified as negative, while scores of 1+, 2+, and 3+ were regarded as positive.

The evaluation was performed by one individual (AC) who was blind regarding the clinical stages of the patients.

Ethics {#ss3}
------

The representative material and patient demographic data were collected after obtaining written informed consent. In all cases, sample acquisition complied with the 1975 Declaration of Helsinki. The study was approved by the Ethical Review Board of the Medical University of Vienna (EK 183/2008).

Statistics {#ss4}
----------

All data are given as mean (range). Statistical analyses were performed using the chi-square test and Fisher's exact test, and p-values of \< 0.05 were considered significant.

Results {#ss5}
=======

Although the clinical symptoms and the grade of contracture were used as indications for surgery, the distribution covered all clinical stages. According to Iselin's classification ([@REF0011]), 6 of 31 patients were classified as stage I, 8 as stage II, 12 as stage III, and 5 as stage IV.

Histologically, 14 samples were attributed to the involutional phase of the disease and 17 samples to the residual phase, according to the Luck classification. Cellular-rich nodules mainly composed of myofibroblasts, which are characteristic of Dupuytren's tissue, could be shown by positive staining for α-SMA in 14 of 31 samples (involutional phase) (Figure), whereas 17 samples were considered to be lesions in the residual phase. All control samples (CTS) were also negative for α-SMA.

![Immunohistochemical expression of α-SMA (a, b, c); Cx26 (d, e, f); Cx43 (g, h, i), and Cx30 (j, k, l) in tissue sections from the involutional phase of DD (a, d, g, j); in tissue sections from the residual phase of DD (b, e, h, k), and in tissue sections from controls (patients with carpal tunnel syndrome) (c, f, i, l) (magnification 400×).](ORT-85-97-g001){#F1}

Clinical classification according to Iselin did not relate to histology according to Luck's stages or to the expression pattern of connexins, either in the involutional phase or in the residual phase of the disease.

Immunohistochemical staining {#ss6}
----------------------------

At least 1 of the connexins was expressed in 12 of 14 α-SMA positive samples, whereas connexins were detected in only 4 of 17 α-SMA negative samples. Cx26 and Cx43 expression was seen in 12 of 14 samples in the involutional phase and Cx30 expression was seen in 7 of the 14 (Figure). In these 7 cases, all 3 connexins were detected. In the residual phase, GJ protein expression was low; Cx26 and Cx43 were found in 4 of 14 samples and 3 of 14 samples, respectively. No Cx30 expression was detected in the residual phase. None of the GJ proteins studied were expressed in the control samples ([Table 2](#T2){ref-type="table"}).

###### 

Numbers of Cx26-, Cx30-, and Cx43-positive cases in the proliferative and residual phase and in controls

  Protein                               n    Cx26                                                                    Cx30                                                                   Cx43
  ------------------------------------- ---- ----------------------------------------------------------------------- ---------------------------------------------------------------------- ----------------------------------------------------------------------
  Involutional phase (α-SMA positive)   14   12/14 **[^a^](#T2-F1){ref-type="fn"}^,^[^c^](#T2-F3){ref-type="fn"}**   7/14 **[^b^](#T2-F2){ref-type="fn"}^,^[^d^](#T2-F4){ref-type="fn"}**   12/14**[^a^](#T2-F1){ref-type="fn"}^,^[^c^](#T2-F3){ref-type="fn"}**
  Residual phase (α-SMA negative)       17   4/17 **[^a^](#T2-F1){ref-type="fn"}**                                   0/17 **[^b^](#T2-F2){ref-type="fn"}**                                  3/17 **[^a^](#T2-F1){ref-type="fn"}**
  Controls                              7    0 **[^c^](#T2-F3){ref-type="fn"}**                                      0 **[^d^](#T2-F4){ref-type="fn"}**                                     0 **[^c^](#T2-F3){ref-type="fn"}**

Statistically significant between Luck's involutional and residual phases:

**^a^** (p = 0.001)

**^b^** (p = 0.03)

Statistically significant between Luck's involutional phase and controls:

**^c^** (p = 0.01)

**^d^** (p = 0.02)

Expression of Cx26, Cx30, and Cx43 in the involutional phase was higher than in the residual phase (Cx26 and Cx43: p \< 0.001; Cx30: p = 0.03) and in the controls (Cx26 and Cx43: p \< 0.001; Cx30: p = 0.02). Intensity of staining was highest for Cx26 and Cx43.

Discussion {#ss7}
==========

We found expression of Cx26, Cx30, and Cx43 mainly in the involutional phase of DD. This is different from spontaneous epithelial wound healing, where expression of all these connexins is downregulated and Cx26 and Cx30 expression is increased at later stages, at the edges of wound margins. Cx43 is expressed in DD, but loss of Cx43 is essential for the induction of wound healing. We have not found any previous studies that have examined the expression of GJ proteins in tissue specimens of DD.

DD shares many biological features with wound healing. Both processes are characterized by proliferation of fibroblasts and myofibroblasts and by the deposition of collagen III ([@REF0010], [@REF0022], [@REF0021], [@REF0009]). Several structural proteins, including collagen III and signaling molecules such as transforming growth factor-β, fibronection, and the heat shock protein HSP47 ([@REF0010]) are known to be expressed both during wound healing and in DD. Myofibroblasts are implicated in the contraction of both wound granulation tissue and cords characteristic of DD. These cells not only regulate the remodeling of the extracellular matrix, but also produce growth factors that can promote scar formation in the case of DD, or further tissue repair events during normal wound healing.

Wound healing requires communication between different cell types, which is provided by connexins, the protein subunits of GJ channels. The skin has an extensive GJ network, which ensures coordinated regional cellular activity ([@REF0016]). 3 connexins have been described in wound healing: Cx26, Cx30, and Cx43 ([@REF0008], [@REF0005], [@REF0002]).

Cx26 is expressed in proliferative epidermis during wound re-epithelization ([@REF0008], [@REF0005]). Unlike the ear, where at least Cx26 appears to be essential for normal function, there may be redundancy in the skin. Thus, loss of any one connexin is not deleterious unless it also affects the other connexins with which it interacts. Mutations in both Cx26 and Cx30 have been associated with various skin phenotypes linked to non-syndromic deafness in different human populations ([@REF0026]). Cx30 is strongly expressed in the scar epidermis and was found in the epidermis of patients presenting with different hyperproliferative skin disorders ([@REF0014]).

In spontaneous epithelial wound healing, the pattern of connexin expression changes ([@REF0013]). Initially, there is a lack of staining of Cx26, Cx30, and Cx43 in cells at the wound margins and surroundings. This early lack of all 3 of these connexins appears to be important for spontaneous wound healing.

In the subsequent stages, cells at the edges of regenerating epidermis continue to be Cx26- and Cx30-negative, where cells behind the edges or at some distance show an upregulation of Cx26 and Cx30 expression. The loss of Cx43 staining in all cells of the regenerating epidermis at or near the wound margins during the early stages appears to be important for the induction of human wound healing ([@REF0005], [@REF0002], [@REF0006]).

Cx43, the most abundant connexin, appears to have a key role in skin wound healing, and its expression is greatly reduced in keratinocytes migrating into the margins of healing wounds ([@REF0008]). In mouse skin, reducing the expression of Cx43 by conditional gene knockout leads to accelerated incisional wound closure, but is followed by an upregulation of various connexins ([@REF0017]).

In contrast, early upregulation of Cx26 and Cx30 and no loss of Cx43 at or near the wound margins is typical for chronic, non-healing wounds ([@REF0018], Becker at al. 2012). The missing downregulation of Cx43 may contribute to the failure to heal ([@REF0002]).

Significant increases in skin wound healing rates occur by altering GJ-mediated intercellular communication, but the underlying cellular and molecular basis remains unclear ([@REF0025]). Both downregulation of connexin expression in migrating cells and interaction of connexins with the extracellular matrix may be vitally important for cell migration during wound closure. Connexin mimetic peptides have been shown to inhibit GJ in a variety of cell types such as smooth muscle cells, endothelial cells, and fibroblasts ([@REF0013], [@REF0016]). Inhibitors that disrupt GJs result in a significant decrease in myofibroblast activity, and hence contraction. Topical Cx43 knockdown results in significant enhancement of wound-healing rates in different model systems ([@REF0019], [@REF0018]). Inhibitors that disrupt GJs results in higher skin wound healing rates ([@REF0023]).

So, connexins and the change in their expression, especially of Cx43, may offer a therapeutic approach to downregulation of myofibroblast activity in cutaneous and musculoskeletal fibrotic disorders such as DD.

Local recurrence after treatment of DD is common ([@REF0020]). Targeting of specific connexins could provide a new approach to the modulation of cell behavior in DD, as has been seen in wound closure ([@REF0025]).
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